Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loop diuretics dosing in acute heart failure with renal failure: conventional vs CA125-guided strategy
2014-001433-83Phase 4Completed
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of furosemide in Acute Heart Failure (AHF) and acute kidney failure (AKF) (2 arms), sponsored by INCLIVA Biomedical Research Institute. Primary endpoints: Change in renal function at 24 hours and Change in renal function at 72 hours. Started Oct 2014; status: completed.
02
Drugs
furosemide
03
Conditions
Acute Heart Failure (AHF)acute kidney failure (AKF)
Beyond the preview
Go deeper on 2014-001433-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001433-83.